Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Holmström, H. Tran, P. Holme (2012)
Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A – a two‐centre experienceHaemophilia, 18
R. Tavenner (1972)
Use of Tranexamic Acid in Control of Haemorrhage after Extraction of Teeth in Haemophilia and Christmas DiseaseBritish Medical Journal, 2
Hematology, Volume 2
G. Ingram, P. Inglish, A. Bennett (1972)
Tranexamic acid for prophylaxis in haemophilia.Journal of Clinical Pathology, 25
M. Laffan, W. Lester, J. O’Donnell, A. Will, R. Tait, A. Goodeve, C. Millar, D. Keeling (2014)
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in HaematologyBritish Journal of Haematology, 167
P. Walsh, C. Rizza, B. Evans, L. Aledort (1975)
THE THERAPEUTIC ROLE OF EPSILON‐AMINOCAPROIC ACID (EACA) FOR DENTAL EXTRACTIONS IN HEMOPHILIACSAnnals of the New York Academy of Sciences, 240
C. Négrier, J. Goudemand, Y. Sultan, Marie-Anne Bertrand, Chantal Rothschild, P. Lauroua (1997)
Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX InhibitorsThrombosis and Haemostasis, 77
C. Forbes, R. Barr, G. Reid, C. Thomson, C. Prentice, G. Nicol, A. Douglas (1972)
Tranexamic Acid in Control of Haemorrhage after Dental Extraction in Haemophilia and Christmas DiseaseBritish Medical Journal, 2
S. Okamoto, U. Okamoto (1962)
AMINO-METHYL-CYCLOHEXANE-CARBOXYLIC ACID: AMCHAThe Keio Journal of Medicine, 11
H. Shakur, I. Roberts, R. Bautista, J. Caballero, T. Coats, Y. Dewan, H. El-Sayed, Tamar Gogichaishvili, Sanjay Gupta, Jorge Herrera, B. Hunt, P. Iribhogbe, M. Izurieta, H. Khamis, E. Komolafe, María Marrero, J. Mejia-Mantilla, J. Miranda, C. Morales, O. Olaomi, F. Olldashi, P. Perel, R. Peto, P. Ramana, R. Ravi, Surakrant Yutthakasemsunt (2010)
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 376
Cochrane Database Syst Rev, 11
Waly Ng (1995)
Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions.Egyptian dental journal, 41
M. Verstraete, C. Ruys (1967)
Double-blind experiments on the effect of a peanut extract on the bleeding incidence in 92 haemophiliacs.British Medical Journal, 4
C. Lee, C. Chi, S. Pavord, P. Bolton-Maggs, D. Pollard, A. Hinchcliffe-Wood, R. Kadir (2006)
The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ OrganizationHaemophilia, 12
A. Bennett, G. Ingram, P. Inglish (1973)
Antifibrinolytic Treatment in Haemophilia: A Controlled Trial of Prophylaxis with Tranexamic AcidBritish Journal of Haematology, 24
C. Rea, Jonathan Foley, O. Okaisabor, Benny Sørensen (2014)
FXIII: mechanisms of action in the treatment of hemophilia AJournal of Thrombosis and Haemostasis, 12
P. Walsh, C. Rizza, J. Matthews, J. Eipe, P. Kernoff, M. Coles, A. Bloom, B. Kaufman, P. Beck, C. Hanan, R. Biggs (1971)
Epsilon‐Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled TrialBritish Journal of Haematology, 20
L. Dai, D. Bevan, S. Rangarajan, B. Sørensen, M. Mitchell (2011)
Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasmaHaemophilia, 17
H. Mohri (2002)
High Dose of Tranexamic Acid for Treatment of Severe Menorrhagia in Patients with von Willebrand DiseaseJournal of Thrombosis and Thrombolysis, 14
A. Gordon, G. Mcnicol, A. Dubber, G. Mcdonald, A. Douglas (1965)
Clinical Trial of Epsilon-aminocaproic Acid in Severe HaemophiliaBritish Medical Journal, 1
I. Roberts, T. Coats, P. Edwards, I. Gilmore, V. Jairath, K. Ker, D. Manno, H. Shakur, S. Stanworth, A. Veitch (2014)
HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trialTrials, 15
J. Foley, M. Nesheim, G. Rivard, K. Brummel‐Ziedins (2012)
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia AHaemophilia, 18
S. Nuvvula, K. Gaddam, R. Kamatham (2014)
Efficacy of tranexamic acid mouthwash as an alternative for factor replacement in gingival bleeding during dental scaling in cases of hemophilia: A randomized clinical trialContemporary Clinical Dentistry, 5
S. Okamoto (2008)
PLASMIN AND ANTIPLASMIN THEIR PATHOLOGIC PHYSIOLOGY
A. Coppola, J. Windyga, A. Tufano, C. Yeung, M. Minno (2015)
Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.The Cochrane database of systematic reviews, 2
A. Hvas, H. SØrensen, L. Norengaard, K. Christiansen, J. Ingerslev, B. Sørensen (2007)
Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia AJournal of Thrombosis and Haemostasis, 5
K. Brummel‐Ziedins, R. Branda, S. Butenas, K. Mann (2009)
Discordant fibrin formation in hemophiliaJournal of Thrombosis and Haemostasis, 7
S. Sindet‐Pedersen, S. Stenbjerg (1986)
Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery.Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 44 9
R. Kadir, Christine Lee, C. Sabin, D. Pollard, D. Economides (1998)
Pregnancy in women with von Willebrand's disease or factor XI deficiencyBJOG: An International Journal of Obstetrics & Gynaecology, 105
(1991)
Tranexamic acid therapy: effective treatment in heavy menstrual bleeding: clinical update on safety
MarioV. Bisordi (1964)
PEANUT FLOUR IN HÆMOPHILIAThe Lancet, 284
S. Okamoto (1959)
PLASMIN AND ANTIPLASMINThe Keio Journal of Medicine, 8
Y. Dewan, E. Komolafe, J. Mejia-Mantilla, P. Perel, I. Roberts, H. Shakur (2012)
CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trialTrials, 13
A. Ducloy-Bouthors, B. Jude, A. Duhamel, F. Broisin, C. Huissoud, H. Keita-Meyer, L. Mandelbrot, N. Tillouche, S. Fontaine, F. Goueff, S. Depret-Mosser, B. Vallet, S. Susen (2011)
High-dose tranexamic acid reduces blood loss in postpartum haemorrhageCritical Care, 15
I. Raza, R. Davenport, C. Rourke, S. Platton, J. Manson, C. Spoors, S. Khan, H. De’Ath, S. Allard, D. Hart, K. Pasi, B. Hunt, S. Stanworth, P. Maccallum, K. Brohi (2013)
The incidence and magnitude of fibrinolytic activation in trauma patientsJournal of Thrombosis and Haemostasis, 11
H. Tran, B. Sørensen, C. Rea, S. Bjørnsen, T. Ueland, A. Pripp, G. Tjønnfjord, P. Holme (2014)
Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitorsHaemophilia, 20
J. Astermark, S. Donfield, D. DiMichele, A. Gringeri, S. Gilbert, J. Waters, E. Berntorp (2007)
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study.Blood, 109 2
D. Collen, R. Lijnen (1985)
The fibrinolytic system in man: an overview
U. Okamoto (1962)
Amino-methyl-cyclohexane-carboxylic acid A new potent inhibitor of fibrinolysis
A. Davis, Meghan Walsh, P. Mccarthy, G. Brown, S. Roberts, Huyen Tran, A. Street, C. Fong, W. Kemp (2013)
Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot studyHaemophilia, 19
C. Hermans, C. Altisent, A. Bátorová, H. Chambost, P. Moerloose, A. Karafoulidou, R. Klamroth, M. Richards, Barry White, G. Dolan (2009)
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendationsHaemophilia, 15
Sam Schulman, J. Loogna, R. Wallensten (2004)
Minimizing factor requirements for surgery without increased riskHaemophilia, 10
Alexander Reiner, William Bell (1984)
The fibrinolytic system in man.Critical reviews in oncology/hematology, 2 1
P. Kouides, Vanessa Byams, C. Philipp, S. Stein, J. Heit, A. Lukes, Nyasha Skerrette, Nicole Dowling, B. Evatt, C. Miller, Sally Owens, R. Kulkarni (2009)
Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acidBritish Journal of Haematology, 145
Thomas Jessing, C. Fenger-Eriksen (2016)
[Tranexamic acid for upper gastrointestinal bleeding].Ugeskrift for laeger, 178 15
I. Roberts, H. Shakur, A. Afolabi, K. Brohi, T. Coats, Y. Dewan, S. Gando, G. Guyatt, B. Hunt, C. Morales, P. Perel, D. Prieto-Merino, T. Woolley (2011)
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trialThe Lancet, 377
C. Rea, J. Foley, J. Foley, J. Foley, J. Ingerslev, B. Sørensen, B. Sørensen (2011)
Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia AJournal of Thrombosis and Haemostasis, 9
C. Lindoff, G. Rybo, B. Åstedt (1993)
Treatment with Tranexamic Acid during Pregnancy, and the Risk of Thrombo-Embolic ComplicationsThrombosis and Haemostasis, 70
AbstractTranexamic acid (TXA) is a synthetic antifibrinolytic drug used widely used to control bleeding complications in a wide variety of clinical situations. Soon after its development in the 1960s it found use in treatment of women with menorrhagia, and in inherited bleeding disorders. Subsequently it was used in surgery and with proven efficacy to reduce transfusion requirements and bleeding complications. Recent meta-analysis have provided further evidence of efficacy and safety. Tranexamic acid is now on the World Health Organization’s (WHO) list of essential drugs, and is the focus of ongoing worldwide trials. Similarly, there is increasing evidence base in both congenital and acquired bleeding disorders. We present a clinical narrative of the antifibrinolytic system and associated drugs to accompany the pharmacy review by Chaplin et al, with the aim of highlighting the evolution of TXA use in bleeding disorders over recent decades.
The Journal of Haemophilia Practice – de Gruyter
Published: Jul 1, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.